CheckMate 73 L: A phase 3 study comparing nivolumab plus concurrent chemoradiotherapy followed by nivolumab ± ipilimumab versus concurrent chemoradiotherapy followed by durvalumab for previously untreated, locally advanced stage III non-small cell lung cancer
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI